Tech World Israel
SEE OTHER BRANDS

Hottest science and technology news from Israel

Tech World Israel: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech World Israel.

Press releases published on June 9, 2025

Unibeam Raises $6M Seed Round to Redefine Authentication With Friction-Free Cryptographic Technology

Unibeam Raises $6M Seed Round to Redefine Authentication With Friction-Free Cryptographic Technology

TEL AVIV, ISRAEL, June 9, 2025 /⁨EINPresswire.com⁩/ -- Unibeam, an Israeli startup revolutionizing digital identity verification, has secured $6 million in seed funding led by NFX, with participation from AnD Ventures. The company has introduced a …

BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript

BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript

In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 trial of D-PLEX100 for preventing surgical site infections (SSIs) in abdominal colorectal surgery patients with large incisions. The …

SaverOne Further Broadens its Global Expansion with a new Agreement with CEMEX Germany

SaverOne Further Broadens its Global Expansion with a new Agreement with CEMEX Germany

The expansion Continues CEMEX Rollout of SaverOne’s Safety Systems Across its Global Operations Petah Tikvah, Israel, June 09, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in developing …

PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints

PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints

D-PLEX100 successfully met the primary efficacy endpoint, with statistically significant results (p<0.005) in 798 patients with large abdominal surgery incisions. The trial successfully met all key secondary efficacy endpoints, including a 58% reduction in …

Oddity Finance LLC Announces Proposed $350 Million Offering of 0% Exchangeable Senior Notes Due 2030

Oddity Finance LLC Announces Proposed $350 Million Offering of 0% Exchangeable Senior Notes Due 2030

As of March 31, 2025, ODDITY had $257 million in cash, and an undrawn $200 million credit line Capital raise gives ODDITY additional firepower to play offense and pursue future opportunities in a volatile world A portion of the proceeds will be used to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service